{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T19:12:40Z","timestamp":1788635560205,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:00:00Z","timestamp":1788566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:00:00Z","timestamp":1788566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"DOI":"10.1007\/s10554-026-03824-4","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T06:29:29Z","timestamp":1788589769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sex differences in coronary plaque stabilization with evolocumab: a post hoc analysis of the YELLOW III trial"],"prefix":"10.1007","author":[{"given":"Keisuke","family":"Yasumura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Goldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliya","family":"Vengrenyuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JiaJia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pruthvi C.","family":"Revaiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Hooda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raman","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahil","family":"Khera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Kapur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Sweeny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagat","family":"Narula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Mehran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samin","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7189-3307","authenticated-orcid":false,"given":"Annapoorna S.","family":"Kini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,5]]},"reference":[{"key":"3824_CR1","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","volume":"366","author":"C Baigent","year":"2005","unstructured":"Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R (2005) Cholesterol Treatment Trialists\u2019 (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366:1267\u20131278","journal-title":"Lancet"},{"key":"3824_CR2","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","volume":"38","author":"BA Ference","year":"2017","unstructured":"Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, Hegele RA, Krauss RM, Raal FJ, Schunkert H, Watts GF, Bor\u00e9n J, Fazio S, Horton JD, Masana L, Nicholls SJ, Nordestgaard BG, van de Sluis B, Taskinen MR, Tokg\u00f6zoglu L, Landmesser U, Laufs U, Wiklund O, Stock JK, Chapman MJ, Catapano AL (2017) Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J 38:2459\u20132472. https:\/\/doi.org\/10.1093\/eurheartj\/ehx144","journal-title":"Eur Heart J"},{"key":"3824_CR3","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1001\/jama.2012.366","volume":"307","author":"SM Boekholdt","year":"2012","unstructured":"Boekholdt SM, Arsenault BJ, Mora S, Pedersen TR, LaRosa JC, Nestel PJ, Simes RJ, Durrington P, Hitman GA, Welch KMA, DeMicco DA, Zwinderman AH, Clearfield MB, Downs JR, Tonkin AM, Colhoun HM, Gotto AM Jr, Ridker PM, Kastelein JJP (2012) Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis. JAMA 307:1302\u20131309","journal-title":"JAMA"},{"key":"3824_CR4","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","volume":"372","author":"CP Cannon","year":"2015","unstructured":"Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Oude Ophuis T, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM (2015) IMPROVE-IT Investigators. Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med 372:2387\u20132397","journal-title":"N Engl J Med"},{"key":"3824_CR5","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","volume":"376","author":"MS Sabatine","year":"2017","unstructured":"Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA, Kuder JF, Wang H, Liu T, Wasserman SM, Sever PS, Pedersen TR (2017) FOURIER Steering Committee and Investigators. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med 376:1713\u20131722","journal-title":"N Engl J Med"},{"key":"3824_CR6","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1056\/NEJMoa1501031","volume":"372","author":"JG Robinson","year":"2015","unstructured":"Robinson JG, Farnier M, Krempf M, Bergeron J, Luc G, Averna M, Stroes ES, Langslet G, Raal FJ, El Shahawy M, Koren MJ, Lepor NE, Lorenzato C, Pordy R, Chaudhari U, Kastelein JJP (2015) ODYSSEY LONG TERM Investigators. Efficacy and safety of alirocumab in reducing lipids and cardiovascular events. N Engl J Med 372:1489\u20131499. https:\/\/doi.org\/10.1056\/NEJMoa1501031 Epub 2015 Mar 15","journal-title":"N Engl J Med"},{"key":"3824_CR7","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1161\/CIRCULATIONAHA.120.051231","volume":"143","author":"RJG Hartman","year":"2021","unstructured":"Hartman RJG, Owsiany K, Ma L, Koplev S, Hao K, Slenders L, Civelek M, Mokry M, Kovacic JC, Pasterkamp G, Owens G, Bj\u00f6rkegren JLM, den Ruijter HM (2021) Sex-stratified gene regulatory networks reveal female key driver genes of atherosclerosis involved in smooth muscle cell phenotype switching. Circulation 143:713\u2013726","journal-title":"Circulation"},{"key":"3824_CR8","doi-asserted-by":"publisher","first-page":"117279","DOI":"10.1016\/j.atherosclerosis.2023.117279","volume":"384","author":"TR Sakkers","year":"2023","unstructured":"Sakkers TR, Mokry M, Civelek M, Erdmann J, Pasterkamp G, Diez Benavente E, den Ruijter HM (2023) Sex differences in the genetic and molecular mechanisms of coronary artery disease. Atherosclerosis 384:117279","journal-title":"Atherosclerosis"},{"key":"3824_CR9","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1161\/CIRCRESAHA.120.315930","volume":"126","author":"JJ Man","year":"2020","unstructured":"Man JJ, Beckman JA, Jaffe IZ (2020) Sex as a biological variable in atherosclerosis. Circ Res 126:1297\u20131319","journal-title":"Circ Res"},{"key":"3824_CR10","doi-asserted-by":"publisher","first-page":"100669","DOI":"10.1016\/j.jacadv.2023.100669","volume":"2","author":"F Berro Rivera","year":"2023","unstructured":"Berro Rivera F, Cha SW, Aparece JP, Rocimo A, Ong BA, Golbin JM, Alfonso PG, Enkhmaa B, Khan SU, Cainzos-Achirica M, Volgman AS, Navar AM, Shah NP (2023) Sex differences in cardiovascular outcomes and cholesterol-lowering efficacy of PCSK9 inhibitors: systematic review and meta-analysis. JACC Adv 2:100669","journal-title":"JACC Adv"},{"key":"3824_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa2514428","volume":"394","author":"EA Bohula","year":"2026","unstructured":"Bohula EA, Marston NA, Bhatia AK, De Ferrari GM, Leiter LA, Nicolau JC, Park JG, Kuder JF, Murphy SA, Walsh E, Wang H, Blaha V, Budaj A, Cornel JH, Goudev A, Kiss RG, Lorenzatti AJ, Parkhomenko A, Cyrille M, Paiva da Silva Lima G, Ohman EM, Giugliano RP, Sabatine MS, VESALIUS-CV Investigators (2026) Evolocumab in patients without a previous myocardial infarction or stroke. N Engl J Med 394:117\u2013127","journal-title":"N Engl J Med"},{"key":"3824_CR12","doi-asserted-by":"publisher","first-page":"320","DOI":"10.4244\/EIJ-D-16-00361","volume":"13","author":"ME Ten Haaf","year":"2017","unstructured":"Ten Haaf ME, Rijndertse M, Cheng JM, de Boer SP, Garcia-Garcia HM, van Geuns RM, Regar E, Lenzen MJ, Appelman Y, Boersma E (2017) Sex differences in plaque characteristics by intravascular imaging in patients with coronary artery disease. EuroIntervention 13:320\u2013328","journal-title":"EuroIntervention"},{"key":"3824_CR13","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jcmg.2025.12.013","volume":"19","author":"AS Kini","year":"2026","unstructured":"Kini AS, Vengrenyuk Y, Liu J, Yasumura K, Revaiah PC, Mandava A, Shah H, Sweeny JM, Khera S, Kapur V, Melarcode-Krishnamoorthy P, Hooda A, Minatoguchi S, Baruah N, Pineda DA, Chen V, Ellis E, Hahn A, Krishnan P, Baber U, Moreno PR, Mehran R, Sebra R, Boerwinkle E, Zhou X, Narula J, Sharma SK (2026) Intracoronary imaging and transcriptomic characteristics before and after maximum lipid-lowering therapy: YELLOW-III study of evolocumab and maximum statin therapy in chronic coronary disease. JACC Cardiovasc Imaging 19:516\u2013534","journal-title":"JACC Cardiovasc Imaging"},{"key":"3824_CR14","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/eurheartj\/ehp433","volume":"31","author":"F Prati","year":"2010","unstructured":"Prati F, Regar E, Mintz GS, Arbustini E, Di Mario C, Jang IK, Akasaka T, Costa M, Guagliumi G, Grube E, Ozaki Y, Pinto F, Serruys PWJ (2010) Expert\u2019s OCT Review Document. Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis. Eur Heart J 31:401\u2013415","journal-title":"Eur Heart J"},{"key":"3824_CR15","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.jacc.2011.09.079","volume":"59","author":"GJ Tearney","year":"2012","unstructured":"Tearney GJ, Regar E, Akasaka T, Adriaenssens T, Barlis P, Bezerra HG, Bouma B, Bruining N, Cho JM, Chowdhary S, Costa MA, de Silva R, Dijkstra J, Di Mario C, Dudek D, Falk E, Feldman MD, Fitzgerald P, Garcia-Garcia HM, Gonzalo N, Granada JF, Guagliumi G, Holm NR, Honda Y, Ikeno F, Kawasaki M, Kochman J, Koltowski L, Kubo T, Kume T, Kyono H, Lam CCS, Lamouche G, Lee DP, Leon MB, Maehara A, Manfrini O, Mintz GS, Mizuno K, Morel MA, Nadkarni S, Okura H, Otake H, Pietrasik A, Prati F, R\u00e4ber L, Radu MD, Rieber J, Riga M, Rollins A, Rosenberg M, Sirbu V, Serruys PWJC, Shimada K, Shinke T, Shite J, Siegel E, Sonoda S, Suter M, Takarada S, Tanaka A, Terashima M, Thim T, Uemura S, Ughi GJ, van Beusekom HMM, van der Steen AFW, van Es GA, van Soest G, Virmani R, Waxman S, Weissman NJ, Weisz G (2012) International Working Group for Intravascular Optical Coherence Tomography. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies. J Am Coll Cardiol 59:1058\u20131072","journal-title":"J Am Coll Cardiol"},{"key":"3824_CR16","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.jacc.2016.10.028","volume":"69","author":"AS Kini","year":"2017","unstructured":"Kini AS, Vengrenyuk Y, Yoshimura T, Matsumura M, Pena J, Baber U, Moreno P, Mehran R, Maehara A, Sharma S, Narula J (2017) Fibrous cap thickness by optical coherence tomography in vivo. J Am Coll Cardiol 69:644\u2013657","journal-title":"J Am Coll Cardiol"},{"key":"3824_CR17","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.jacc.2016.10.029","volume":"69","author":"AS Kini","year":"2017","unstructured":"Kini AS, Vengrenyuk Y, Shameer K, Maehara A, Purushothaman M, Yoshimura T, Matsumura M, Aquino M, Haider N, Johnson KW, Readhead B, Kidd BA, Feig JE, Krishnan P, Sweeny J, Milind M, Moreno P, Mehran R, Kovacic JC, Baber U, Dudley JT, Narula J, Sharma S (2017) Intracoronary imaging, cholesterol efflux, and transcriptomes after intensive statin treatment: the YELLOW II study. J Am Coll Cardiol 69:628\u2013640","journal-title":"J Am Coll Cardiol"},{"key":"3824_CR18","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1038\/s41598-018-35773-x","volume":"9","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Wei TF, Zhao B, Yin Z, Shi QX, Liu PL, Liu LF, Liu L, Zhao JT, Mao S, Rao MM, Wang SL, Chen YD (2019) Sex differences associated with circulating PCSK9 in patients presenting with acute myocardial infarction. Sci Rep 9:3113","journal-title":"Sci Rep"},{"key":"3824_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.atherosclerosis.2020.07.014","volume":"309","author":"N Ferri","year":"2020","unstructured":"Ferri N, Ruscica M, Coggi D, Bonomi A, Amato M, Frigerio B, Sansaro D, Ravani A, Veglia F, Capra N, Lupo MG, Macchi C, Castelnuovo S, Savonen K, Silveira A, Kurl S, Giral P, Pirro M, Strawbridge RJ, Gigante B, Smit AJ, Tremoli E, Colombo GI, Baldassarre D (2020) IMPROVE study group. Sex-specific predictors of PCSK9 levels in a European population: the IMPROVE study. Atherosclerosis 309:39\u201346","journal-title":"Atherosclerosis"},{"key":"3824_CR20","doi-asserted-by":"publisher","first-page":"953845","DOI":"10.3389\/fphar.2022.953845","volume":"13","author":"F Jia","year":"2022","unstructured":"Jia F, Fei SF, Tong DB, Xue C, Li JJ (2022) Sex difference in circulating PCSK9 and its clinical implications. Front Pharmacol 13:953845","journal-title":"Front Pharmacol"},{"key":"3824_CR21","doi-asserted-by":"publisher","first-page":"1254114","DOI":"10.3389\/fcvm.2023.1254114","volume":"10","author":"L Alonso-Herranz","year":"2023","unstructured":"Alonso-Herranz L, Albarr\u00e1n-Ju\u00e1rez J, Bentzon JF (2023) Mechanisms of fibrous cap formation in atherosclerosis. Front Cardiovasc Med 10:1254114","journal-title":"Front Cardiovasc Med"},{"key":"3824_CR22","doi-asserted-by":"publisher","first-page":"e004506","DOI":"10.1161\/CIRCIMAGING.116.004506","volume":"9","author":"Y Kataoka","year":"2016","unstructured":"Kataoka Y, Puri R, Hammadah M, Duggal B, Uno K, Kapadia SR, Tuzcu EM, Nissen SE, King P, Nicholls SJ (2016) Sex differences in nonculprit coronary plaque microstructures on frequency-domain optical coherence tomography in acute coronary syndromes and stable coronary artery disease. Circ Cardiovasc Imaging 9:e004506","journal-title":"Circ Cardiovasc Imaging"},{"key":"3824_CR23","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jacc.2009.09.007","volume":"55","author":"MCA Kramer","year":"2010","unstructured":"Kramer MCA, Rittersma SZH, de Winter RJ, Ladich ER, Fowler DR, Liang YH, Kutys R, Carter-Monroe N, Kolodgie FD, van der Wal AC, Virmani R (2010) Relationship of thrombus healing to underlying plaque morphology in sudden coronary death. J Am Coll Cardiol 55:122\u2013132","journal-title":"J Am Coll Cardiol"},{"key":"3824_CR24","doi-asserted-by":"publisher","first-page":"e015227","DOI":"10.1161\/CIRCIMAGING.123.015227","volume":"16","author":"LM Seegers","year":"2023","unstructured":"Seegers LM, Yeh DDF, Yonetsu T, Sugiyama T, Minami Y, Soeda T, Araki M, Nakajima A, Yuki H, Kinoshita D, Suzuki K, Niida T, Lee H, McNulty I, Nakamura S, Kakuta T, Fuster V, Jang IK (2023) Sex differences in coronary atherosclerotic phenotype and healing pattern on optical coherence tomography imaging. Circ Cardiovasc Imaging 16:e015227","journal-title":"Circ Cardiovasc Imaging"},{"key":"3824_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/1074248419868699","volume":"25","author":"KM Kassem","year":"2020","unstructured":"Kassem KM, Ali M, Rhaleb NE (2020) Interleukin 4: its role in hypertension, atherosclerosis, valvular, and nonvalvular cardiovascular diseases. J Cardiovasc Pharmacol Ther 25:7\u201314","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"3824_CR26","doi-asserted-by":"publisher","first-page":"EVIDoa2100009","DOI":"10.1056\/EVIDoa2100009","volume":"1","author":"TX Zhao","year":"2022","unstructured":"Zhao TX, Sriranjan RS, Tuong ZK, Lu Y, Sage AP, Nus M, Hubsch A, Kaloyirou F, Vamvaka E, Helmy J, Kostapanos M, Jalaludeen N, Klatzmann D, Tedgui A, Rudd JHF, Horton SJ, Huntly BJ, Hoole SP, Bond SP, Clatworthy MR, Cheriyan J, Mallat Z (2022) Regulatory T-cell response to low-dose interleukin-2 in ischemic heart disease. NEJM Evid 1:EVIDoa2100009","journal-title":"NEJM Evid"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-026-03824-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10554-026-03824-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-026-03824-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T19:02:43Z","timestamp":1788634963000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10554-026-03824-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,5]]},"references-count":26,"alternative-id":["3824"],"URL":"https:\/\/doi.org\/10.1007\/s10554-026-03824-4","relation":{},"ISSN":["1875-8312"],"issn-type":[{"value":"1875-8312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,5]]},"assertion":[{"value":"19 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr Mehran has received institutional research grants from Abbott, Abiomed, Applied Therapeutics, Arena, Astra-Zeneca, Bayer, Biosensors, Boston Scientific, Bristol Myers Squibb, CardiaWave, CellAegis, CERC, Chiesi, Concept Medical, CSL Behring, DSI, Insel Gruppe, Medtronic, Novartis Pharmaceuticals, OrbusNeich, Philips, Transverse Medical, and Zoll; has received personal fees from the American College of Cardiology, Boston Scientific, the California Institute for Regenerative Medicine, Cine-Med Research, Janssen, WebMD, and the Society for Cardiovascular Angiography and Interventions; has received consulting fees paid to the institution from Abbott, Abiomed, AM-Pharma, Alleviant Medical, Bayer, Beth Israel Deaconess, CardiaWave, CeloNova, Chiesi, Concept Medical, DSI, Duke University, Idorsia Pharmaceuticals, Medtronic, Novartis, and Philips; holds equity (<1%) in Applied Therapeutics, Elixir Medical, STEL, and CONTROLRAD (spouse); has served as a scientific advisory board member for the American Medical Association; and has a spouse who has served as a scientific advisory board member for Biosensors (spouse). Dr Khera has received consulting or speaker fees from Medtronic, Edwards Lifesciences, Abbott Structural Heart, Eastend Medical, Terumo, and Zoll Medical; has served as a proctor for Medtronic, W.L.Gore & Associates and Abbott Structural Heart; and is also global principal investigator of a study funded by Teleflex (no compensation). All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the principles of the Declaration of Helsinki. The study protocol for the YELLOW III trial was approved by the Institutional Review Board at Mount Sinai Hospital, and the present post hoc analysis was conducted using de-identified data in accordance with institutional guidelines.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients provided written informed consent prior to enrollment in the YELLOW III trial.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}}]}}